0001683168-22-003046.txt : 20220429 0001683168-22-003046.hdr.sgml : 20220429 20220429141313 ACCESSION NUMBER: 0001683168-22-003046 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 EFFECTIVENESS DATE: 20220429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sunshine Biopharma, Inc CENTRAL INDEX KEY: 0001402328 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 205566275 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-443893 FILM NUMBER: 22873583 BUSINESS ADDRESS: STREET 1: 6500 TRANS-CANADA HIGHWAY STREET 2: 4TH FLOOR CITY: POINTE-CLAIRE STATE: A8 ZIP: H9R 0A5 BUSINESS PHONE: 514-426-6161 MAIL ADDRESS: STREET 1: 6500 TRANS-CANADA HIGHWAY STREET 2: 4TH FLOOR CITY: POINTE-CLAIRE STATE: A8 ZIP: H9R 0A5 FORMER COMPANY: FORMER CONFORMED NAME: Mountain West Business Solutions, Inc DATE OF NAME CHANGE: 20071030 FORMER COMPANY: FORMER CONFORMED NAME: mountain west business solutions,inc DATE OF NAME CHANGE: 20070607 D 1 primary_doc.xml X0708 D LIVE 0001402328 Sunshine Biopharma, Inc 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 514-426-6161 COLORADO None Mountain West Business Solutions, Inc mountain west business solutions,inc Corporation true Steve N. Slilaty 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Executive Officer Director President, Chief Executive Officer and Chairman Abderrazzak Merzouki 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Executive Officer Director Chief Operating Officer Camille Sebaaly 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Executive Officer Chief Financial Officer and Secretary Rabi Kiderchah 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Director David Natan 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Director Andrew Keller 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 QUEBEC, CANADA H9R 0A5 Director Pharmaceuticals Decline to Disclose 06b false 2022-04-25 false true true false 0 Aegis Capital Corp. 15007 None None 810 7TH AVE 18TH AND 22ND FLOOR NEW YORK NY NEW YORK 10019 CT CONNECTICUT NV NEVADA NY NEW YORK false 19497618 19497618 0 false 9 2340001 0 Includes non accountable expense allowance of 2% of gross proceeds. Placement agent will also receive 5% fee for any warrant excercises. 0 false Sunshine Biopharma, Inc /s/ Steve N. Slilaty Steve N. Slilaty Chief Executive Officer 2022-04-29